| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |